ConductScience.org, home

Trial · NCT01769378

Results by group55

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Change From Baseline in Glycosylated Hemoglobin A1c (HbA1c) at 24 WeeksDulaglutide-1.38Standard Error 0.08percent change of HbA1c
Change From Baseline in Glycosylated Hemoglobin A1c (HbA1c) at 24 WeeksPlacebo-0.11Standard Error 0.14percent change of HbA1c
Percentage of Participants Who Achieve HbA1c <7.0% and ≤6.5% at 24 WeeksDulaglutidePercent Achieved <7.0 HbA1c Level55.3percentage of participants
Percentage of Participants Who Achieve HbA1c <7.0% and ≤6.5% at 24 WeeksPlaceboPercent Achieved <7.0 HbA1c Level18.9percentage of participants
Percentage of Participants Who Achieve HbA1c <7.0% and ≤6.5% at 24 WeeksDulaglutidePercent Achieved ≤6.5 HbA1c Level40.0percentage of participants
Percentage of Participants Who Achieve HbA1c <7.0% and ≤6.5% at 24 WeeksPlaceboPercent Achieved ≤6.5 HbA1c Level9.4percentage of participants
Change From Baseline in Fasting Serum Glucose (FSG) at 24 WeeksDulaglutide-30.60Standard Error 4.46milligrams per deciliter (mg/dL)
Change From Baseline in Fasting Serum Glucose (FSG) at 24 WeeksPlacebo2.93Standard Error 6.76milligrams per deciliter (mg/dL)
Change From Baseline in Body Weight at 24 WeeksDulaglutide-0.91Standard Error 0.21kilograms (kg)
Change From Baseline in Body Weight at 24 WeeksPlacebo-0.24Standard Error 0.40kilograms (kg)
Change From Baseline in Body Mass Index (BMI) at 24 WeeksDulaglutide-0.32Standard Error 0.08kilograms per/square meter kg/m^2
Change From Baseline in Body Mass Index (BMI) at 24 WeeksPlacebo-0.10Standard Error 0.15kilograms per/square meter kg/m^2
Change From Baseline in Mean of All 7-Point Self Monitored Plasma Glucose (SMPG) at 24 WeeksDulaglutide-37.22Standard Error 3.10mg/dL
Change From Baseline in Mean of All 7-Point Self Monitored Plasma Glucose (SMPG) at 24 WeeksPlacebo-8.27Standard Error 4.77mg/dL
Number of Participants With Reported and Adjudicated Cardiovascular EventsDulaglutideAny reported CV events2participants
Number of Participants With Reported and Adjudicated Cardiovascular EventsPlaceboAny reported CV events0participants
Number of Participants With Reported and Adjudicated Cardiovascular EventsDulaglutideAny adjudicated nonfatal CV events2participants
Number of Participants With Reported and Adjudicated Cardiovascular EventsPlaceboAny adjudicated nonfatal CV events0participants
Number of Participants With Reported and Adjudicated Cardiovascular EventsDulaglutideAny confirmed adjudicated CV deaths0participants
Number of Participants With Reported and Adjudicated Cardiovascular EventsPlaceboAny confirmed adjudicated CV deaths0participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01769378/results